📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
LASA SUPERGENERICS LIMITEDLASAPharmaceuticals
Open
8.49
High
8.49
Low
7.93
Close
8.1
Volume
9615
Exchange
nse
Time
21-May-2026

Outlook

Score:

2

Rating:

RISKY

Candlestick Pattern

CandlepatternofLasaSupergenericsis
Long Body
EstimatedStoplossofLasaSupergenericsis
8.49
LasaSupergenericshasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesthetrenddirectionofLasaSupergenericsmaybe
Unpredictableℹ
,butkeepalookoutforfallinprice.

Trend

LasaSupergenericsisin
Sideways trendℹ
.
PriceofLasaSupergenericsis
Upℹ
by

4.25

%.
Target
Buy@

6.34

Sell@

9

Current@

8.1

Volume

ThetradevolumesofLasaSupergenericshavebecome
Deficientℹ
ThoughthevolumetrendforLasaSupergenericsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofLasaSupergenericsis

Down

by

73.64

%

Valuation

ThecurrentmarketpriceofLasaSupergenericsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth101crandtotalassetsworth101cr,thebalancesheetofLasaSupergenericsis:
Balancedℹ
.
Cashflow
LasaSupergenericshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
13.33% i.e. ₹ 2cr spent in operatingℹ
53.33% i.e. ₹ 8cr earned in investingℹ
33.33% i.e. ₹ 5cr spent in financingℹ
0% in otherℹ
LasaSupergenericshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
66.67% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
33.33% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Income
TheincomeofLasaSupergenericsis

₹ 3cr

and

Loss

is:

₹ 6cr

LasaSupergenericsLossesdecreasedby:

71.43

%andIncomeisDownby:

85

%
TheincomeofLasaSupergenericsis

₹ 20cr

and

Loss

is:

₹ 21cr

LasaSupergenericsLossesincreasedby:

50

%andIncomeisDownby:

51.22

%
TheincomeofLasaSupergenericsis

₹ 41cr

and

Loss

is:

₹ 14cr

LasaSupergenericsLossesincreasedby:

380

%andIncomeisUpby:

24.24

%
By using this site you agree to the use of cookies to deliver a better site experience.